Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: a multicenter retrospective cohort study

D Fujimoto, H Yoshioka, Y Kataoka, T Morimoto… - Lung cancer, 2018 - Elsevier
Introduction Nivolumab has been shown to be effective and safe in previously treated
patients with advanced non-small cell lung cancer (NSCLC). However, little is known …
被引用次数：141 相关文章

Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study

D Fujimoto, H Yoshioka, Y Kataoka… - Lung cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction Nivolumab has been shown to be effective and safe in previously treated
patients with advanced non-small cell lung cancer (NSCLC). However, little is known …

Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study

D Fujimoto, H Yoshioka, Y Kataoka… - Lung …, 2018 - lungcancerjournal.info
Introduction Nivolumab has been shown to be effective and safe in previously treated
patients with advanced non-small cell lung cancer (NSCLC). However, little is known …

[引用][C] Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study

D Fujimoto, H Yoshioka, Y Kataoka, T Morimoto… - Lung Cancer, 2018 - cir.nii.ac.jp
Efficacy and safety of nivolumab in previously treated patients with non-small cell lung
cancer: A multicenter retrospective cohort study | CiNii Research CiNii 国立情報学研究所 …
[PDF] academia.edu

[PDF][PDF] Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study

D Fujimotoa, H Yoshiokab, Y Kataokac, T Morimotod… - Lung …, 2018 - academia.edu
Introduction: Nivolumab has been shown to be effective and safe in previously treated
patients with advanced non-small cell lung cancer (NSCLC). However, little is known …

Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study.

D Fujimoto, H Yoshioka, Y Kataoka… - Lung Cancer …, 2018 - europepmc.org
Methods We conducted a 15-center, observational, retrospective cohort study of patients
with advanced NSCLC who received nivolumab monotherapy between January and …